CRYZ, crystallin zeta, 1429

N. diseases: 145; N. variants: 4
Disease: Bladder Neoplasm ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm 		0.050 Biomarker disease BEFREE quinone oxidoreductase 1 (NQO1) and superoxide dismutase 2 (SOD2), modulators of the effects of reactive oxidative species, can influence an individual's susceptibility to these carcinogenic exposures and hence the risk of bladder cancer. 24035474 2014
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm 		0.050 GeneticVariation disease BEFREE Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer. 23873104 2013
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm 		0.050 GeneticVariation disease BEFREE The NAD(P)H:quinone oxidoreductase 1 (NQO1) rs1800566 polymorphism, leading to proline- toserine amino-acid and enzyme activity changes, has been implicated in bladder cancer risk, but individually published studies showed inconsistent results. 23464456 2012
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm 		0.050 GeneticVariation disease BEFREE Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population. 21253823 2011
CUI: C0005695
Disease: Bladder Neoplasm
Bladder Neoplasm 		0.050 GeneticVariation disease BEFREE We investigated the role of glutathione S-transferase (GST) enzymes (M1, T1), methylenetetrahydrofolate (MTHFR) 677 and 1298, and the NAD(P)H:quinone oxidoreductase (NQO1) polymorphisms in a population-based bladder cancer case-control study in Argentina. 15219943 2004